Medicine and Dentistry
Vitamin D
100%
Macrophage
60%
Vitamin D Deficiency
49%
Hypovitaminosis D
49%
Maturity Onset Diabetes of the Young
43%
Endoplasmic Reticulum Stress
36%
Diabetes Mellitus
32%
Atherosclerosis
30%
Cardiovascular Disease
26%
Supplementation
25%
Foam Cell
25%
Cholesterol Transport
24%
Patient with Type 2 Diabetes
23%
Health Outcomes
16%
Cholesterol Metabolism
15%
Ergocalciferol
15%
Insulin Resistance
14%
Diabetes
13%
Vitamin D Receptor
12%
Type 2 Diabetes
12%
Scavenger Receptor
11%
M2 Macrophages
11%
Immunocompetent Cell
11%
Amino Terminal Sequence
10%
Downregulation
10%
Phosphotransferase
10%
Renin Angiotensin Aldosterone System
9%
Oxidized Low Density Lipoprotein
8%
Macrophage Differentiation
8%
Prevalence
7%
Macrophage Migration
7%
Thyrotropin
7%
Liothyronine
7%
Lactation
7%
Coronary Artery Disease
7%
Central Nervous System
7%
Cardiometabolic Risk
7%
Oxidative Stress
7%
Triacylglycerol
7%
African American Health
7%
Cardiovascular System
7%
Hematopoietic Cell
7%
Pharmacotherapy
7%
Antipsychotic
7%
High Fat Food
7%
Randomized Controlled Trial
6%
Intima-Media Thickness
6%
Absorptiometry
6%
Colecalciferol
6%
Body Fat Percentage
6%
Keyphrases
Vitamin D Deficiency
74%
Vitamin D
51%
Type 2 Diabetes Mellitus (T2DM)
46%
Type 2 Diabetic Patients
44%
Macrophages
42%
Endoplasmic Reticulum Stress (ER stress)
38%
Cardiovascular Disease
35%
Foam Cell Formation
28%
Monocytes
23%
Cholesterol Uptake
23%
1,25(OH)2D3
22%
Vitamin D Supplementation
20%
Hypertension
19%
African American
17%
Vitamin D Receptor
17%
1,25(OH)2 Vitamin D
15%
Macrophage Migration
15%
Functional Health
15%
Health Outcomes
15%
Mental Health
15%
Diabetes
14%
Vitamin D3
13%
Insulin Resistance
13%
Vitamin D Status
13%
M2 Macrophages
12%
C-Jun N-terminal Kinase
11%
Diabetic Patients
10%
Renin
10%
Vitamin D Replacement
10%
Diabetic
10%
Induced Hypertension
10%
25-hydroxyvitamin D (25OHD)
10%
Cholesterol Deposition
10%
MiR-106b-5p
9%
Non-diabetic
9%
International Units
9%
Macrophage Phenotype
8%
Monocyte-derived Macrophages
8%
Macrophage Differentiation
8%
Macrophage Cholesterol Metabolism
8%
High Blood Pressure
8%
Accelerated Atherosclerosis
8%
SR-A1
7%
Oxidized Low-density Lipoprotein (ox-LDL)
7%
Risk Factors
7%
Clinical Trials
7%
Free Triiodothyronine
7%
Model Trial
7%
Atherogenic Cholesterol
7%
Cellular Mechanisms
7%
Pharmacology, Toxicology and Pharmaceutical Science
Vitamin D
77%
Diabetes Mellitus
39%
Vitamin D Deficiency
38%
Hypovitaminosis D
38%
Non Insulin Dependent Diabetes Mellitus
34%
Cardiovascular Disease
33%
Ergocalciferol
15%
Atherosclerosis
12%
Pharmacotherapy
11%
Renin
9%
Scavenger Receptor
9%
Fragility Fracture
7%
Triacylglycerol
7%
Hypoglycemia
7%
Clinical Trial
7%
Thyrotropin
7%
Liothyronine
7%
Coronary Artery Disease
7%
Antipsychotic
7%
Cholecalciferol
7%
Vitamin D Receptor
7%
Oxidized Low Density Lipoprotein
6%
Insulin Resistance
6%
Thyrotoxicosis
5%